ChemicalBook >> CAS DataBase List >>BRETYLIUM TOSYLATE

BRETYLIUM TOSYLATE

CAS No.
61-75-6
Chemical Name:
BRETYLIUM TOSYLATE
Synonyms
ornid;asl-603;darentin;bretylan;bretylol;bretylate;darenthin;esulfonicacid;ulfonicacid(1:1);BretyliuM p-Tolu
CBNumber:
CB5239348
Molecular Formula:
C18H24BrNO3S
Molecular Weight:
414.36
MDL Number:
MFCD00038731
MOL File:
61-75-6.mol
Last updated:2023-06-08 09:03:01

BRETYLIUM TOSYLATE Properties

Melting point 97-99°
storage temp. Inert atmosphere,Room Temperature
solubility H2O: soluble50mg/mL
form Solid
color white
InChIKey KVWNWTZZBKCOPM-UHFFFAOYSA-M
FDA UNII 78ZP3YR353
ATC code C01BD02

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302+H312+H332
Precautionary statements  P261-P280-P301+P312+P330
Hazard Codes  Xn
Risk Statements  20/21/22
Safety Statements  36
RTECS  BO9450000
HS Code  2923900100
Toxicity LD50 in mice (mg/kg): 400 orally; 250 i.m. (Goldenthal)
NFPA 704
0
3 0

BRETYLIUM TOSYLATE price More Price(25)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich 1076352 Bretylium tosylate United States Pharmacopeia (USP) Reference Standard 61-75-6 200mg $483 2024-03-01 Buy
Cayman Chemical 29979 Bretylium (tosylate) 61-75-6 10mg $32 2024-03-01 Buy
Cayman Chemical 29979 Bretylium (tosylate) 61-75-6 250mg $456 2024-03-01 Buy
Cayman Chemical 29979 Bretylium (tosylate) 61-75-6 50mg $139 2024-03-01 Buy
Cayman Chemical 29979 Bretylium (tosylate) 61-75-6 100mg $243 2024-03-01 Buy
Product number Packaging Price Buy
1076352 200mg $483 Buy
29979 10mg $32 Buy
29979 250mg $456 Buy
29979 50mg $139 Buy
29979 100mg $243 Buy

BRETYLIUM TOSYLATE Chemical Properties,Uses,Production

Chemical Properties

White Solid

Originator

Bretylate,Wellcome,UK,1973

Uses

Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade. Bretylium tosylate is a class III antiarrhythmic agent and a competitive inhibitor of acetylcholinesterase.

Definition

ChEBI: The tosylate salt of bretylium. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibril ation.

Manufacturing Process

N-o-Bromobenzyl-N,N-dimethylamine (100g) and ethyl p-toluenesulfonate (94 g) were mixed and warmed to 50°-60°C; after standing for either (a) a minimum of 96 hours at 15°-20°C or (b) a minimum of 18 hours at 50°-60°C and cooling to room temperature, a hard, crystalline mass was formed. Recrystallization of this product from acetone (2.0 ml/g of crude solid), followed by filtration and drying to 60°C gave N-o-bromobenzyl-N-ethyl-N,Ndimethylammonium p-toluenesulfonate as a white, crystalline solid, MP 97°- 99°C. For this procedure it was necessary that the reactants were substantially colorless and of a high purity.

brand name

Bretylol (Mayne).

Therapeutic Function

Adrenergic blocker; Antiarrhythmic

General Description

Bretylium tosylate, (o-bromobenzyl)ethyl dimethylammonium p-toluenesulfonate(Bretylol), is an extremely bitter, white, crystalline powder.The chemical is freely soluble in water and alcohol.Bretylium tosylate is an adrenergic neuronal-blockingagent that accumulates selectively in the neurons anddisplaces norepinephrine. Because of this property,bretylium was used initially, under the trade name ofDarenthin, as an antihypertensive agent. It caused posturaldecrease in arterial pressure. This use was discontinuedbecause of the rapid development of tolerance, erratic oralabsorption of the quaternary ammonium compound, andpersistent pain in the parotid gland on prolonged therapy.

Clinical Use

Currently, bretylium is reserved for use in ventriculararrhythmias that are resistant to other therapy. Bretyliumdoes not suppress phase 4 depolarization, a common actionof other antiarrhythmic agents. It prolongs the effectiverefractory period relative to the action potential durationbut does not affect conduction time and is categorized asa class III antiarrhythmic agent. Because bretylium doesnot have properties similar to those of the other antiarrhythmicagents, it has been suggested that its action is aresult of its adrenergic neuronal-blocking properties; theantiarrhythmic properties of the drug, however, are notaffected by administration of reserpine. Bretylium is also alocal anesthetic, but it has not been possible to demonstratesuch an effect on atria of experimental animals, except atvery high concentrations. Therefore, the precise mechanismof the antiarrhythmic action of bretylium remains tobe resolved.

Side effects

The major adverse effect associated with bretylium tosylate is hypotension, including orthostatic hypotension, which may be very severe.

BRETYLIUM TOSYLATE Preparation Products And Raw materials

Global( 97)Suppliers
Supplier Tel Email Country ProdList Advantage
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 47465 58
Career Henan Chemica Co
+86-0371-86658258 15093356674; laboratory@coreychem.com China 30255 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167 1026@dideu.com China 9409 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29322 58
Finetech Industry Limited
+86-27-87465837 +8618971612321 info@finetechnology-ind.com China 9702 58
Dayang Chem (Hangzhou) Co.,Ltd.
571-88938639 +8617705817739 info@dycnchem.com CHINA 52867 58
Alfa Chemistry
+1-5166625404 Info@alfa-chemistry.com United States 21317 58
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
ZHEJIANG JIUZHOU CHEM CO., LTD
+86-0576225566889 +86-13454675544 admin@jiuzhou-chem.com;jamie@jiuzhou-chem.com;alice@jiuzhou-chem.com China 20000 58

View Lastest Price from BRETYLIUM TOSYLATE manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
BRETYLIUM TOSYLATE USP/EP/BP pictures 2021-08-12 BRETYLIUM TOSYLATE USP/EP/BP
61-75-6
US $1.10 / g 1g 99.9% 100 Tons min Dideu Industries Group Limited
(o-bromobenzyl)ethyldimethyl-ammoniup-toluenesulfonate 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium4-methylbenzenesulfonate 2-bromo-n-ethyl-n,n-dimethyl-benzenemethanaminiusaltwith4-methylbenzen darentin dimethylethyl-o-bromobenzylammonium-p-toluenesulphonate esulfonicacid n-ethyl-n-o-bromobenzyl-n,n-dimethylammoniumtosylate ornid ulfonicacid(1:1) Bretylium Tosylate (200 mg) BretyliuM p-Tolu N-(2-BroMobenzyl)-N,N-diMethylethanaMiniuM 4-Methylbenzenesulfonate BretyliuM Tosylate USP 2-bromo-n-ethyl-n,n-dimethyl-benzenemethanaminiusaltwith4-methylbenzenes asl-603 bretylan bretylate bretyliump-toluenesulfonate Bretyliumtosilate bretylol darenthin [O-BROMOBENZYL]ETHYLDIMETHYL-AMMONIUM P-TOLUENESULFONATE BRETYLIUM TOSYLATE BRETYLIUM TOSYLATE ADRENERGIC NEURON BLO BRETYLIUM TOSYLATE, PHARMA (2-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate Bretyliume tosylate Retylium tosylate (2-bromobenzyl)-ethyl-dimethyl-ammonium (2-bromophenyl)methyl-ethyl-dimethylazanium (2-bromophenyl)methyl-ethyl-dimethyl-azanium 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium Bretylium Tosylate (1076352) BRETYLIUM TOSYLATE USP/EP/BP inhibit,Inhibitor,Bretylium,Bretylium tosylate 61-75-6 C18H24BrNO3S C18H24BO3RnS C11H17BrNC7H7O3S Amines Aromatics Intermediates & Fine Chemicals Pharmaceuticals Sulfur & Selenium Compounds